Risk factors for second primary cancers in patients with curatively resected gastric cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
1128 patients who underwent R0 resection for Stage I/II/III GC.
I · Intervention 중재 / 시술
R0 resection for Stage I/II/III GC
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
추출되지 않음
[PURPOSE] Despite improving long-term outcomes after gastrectomy for gastric cancer (GC), screening methods for second primary cancer (SPC) following resection remain challenging.
- 추적기간 64 months
APA
Wakao K, Miyake H, et al. (2025). Risk factors for second primary cancers in patients with curatively resected gastric cancer.. International journal of clinical oncology, 30(10), 2012-2021. https://doi.org/10.1007/s10147-025-02848-5
MLA
Wakao K, et al.. "Risk factors for second primary cancers in patients with curatively resected gastric cancer.." International journal of clinical oncology, vol. 30, no. 10, 2025, pp. 2012-2021.
PMID
40783632 ↗
Abstract 한글 요약
[PURPOSE] Despite improving long-term outcomes after gastrectomy for gastric cancer (GC), screening methods for second primary cancer (SPC) following resection remain challenging. This study aimed to investigate the cumulative incidence and risk factors for SPC in patients with curative resection for GC.
[METHODS] We included 1128 patients who underwent R0 resection for Stage I/II/III GC. Incidence of duplicate cancers before and after gastrectomy was investigated. The cumulative incidence of SPC following gastrectomy was calculated, and the relationship between SPC occurrence and clinicopathological factors was analyzed.
[RESULTS] During a median postoperative follow-up of 64 months, the most common SPCs were lung, prostate, and colorectal cancers. Additionally, lung and pancreatic cancers occurred significantly more frequently after gastrectomy than before. The cumulative incidence of SPCs was 7% at 5 years, 18% at 10 years, and 29% at 15 years. Multivariate analysis identified male sex, postoperative carcinoembryonic antigen (CEA) levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL at one month after gastrectomy as significant factors associated with SPC development.
[CONCLUSION] After gastrectomy for gastric cancer (GC), enhanced surveillance for SPCs can be tailored based on three factors: male sex, postoperative CEA levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL.
[METHODS] We included 1128 patients who underwent R0 resection for Stage I/II/III GC. Incidence of duplicate cancers before and after gastrectomy was investigated. The cumulative incidence of SPC following gastrectomy was calculated, and the relationship between SPC occurrence and clinicopathological factors was analyzed.
[RESULTS] During a median postoperative follow-up of 64 months, the most common SPCs were lung, prostate, and colorectal cancers. Additionally, lung and pancreatic cancers occurred significantly more frequently after gastrectomy than before. The cumulative incidence of SPCs was 7% at 5 years, 18% at 10 years, and 29% at 15 years. Multivariate analysis identified male sex, postoperative carcinoembryonic antigen (CEA) levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL at one month after gastrectomy as significant factors associated with SPC development.
[CONCLUSION] After gastrectomy for gastric cancer (GC), enhanced surveillance for SPCs can be tailored based on three factors: male sex, postoperative CEA levels ≥ 5.0 ng/mL, and albumin levels ≤ 3.8 g/dL.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.